---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-23-000066"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T06:11:13.440402+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# GeneDx Q3: revenue $53M, exome/genome up 42% YoY; cuts FY rev guidance to $187-192M; secures $75M Perceptive debt

## Summary
- Continuing ops revenue $50.4M; exome and genome test revenue $34M (+42% YoY). Adjusted gross margin from cont ops 48%.
- Net loss $42.3M; adjusted net loss $21.2M, improved 70% YoY. Cash burn $42M, down 51% YoY.
- FY2023 revenue guidance lowered to $187-192M (from $205-220M). Path to profitability in 2025 reiterated.
- Entered $75M senior secured credit facility with Perceptive Advisors; initial $50M funded at SOFR+7.5%. Warrants for 800k shares at $3.17.
- Enacted $40M annual cost savings plan including ~10% workforce reduction. Appointed Melanie Duquette as Chief Growth Officer.

## SEC filing metadata
- accession: 0001818331-23-000066
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 1.02, 2.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000066/0001818331-23-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000066/wgs-20231027.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-23-000066
- JSON: https://secwatch.observer/filing/0001818331-23-000066.json
- Plain text: https://secwatch.observer/filing/0001818331-23-000066.txt

## Key facts
- Debt Financings
  GeneDx Holdings Corp. incurred term loan of up to $75.0 million with Perceptive Credit Holdings IV, LP at Term SOFR plus 7.5% maturing October 27, 2028.
  - Instrument: term loan
  - Principal: up to $75.0 million
  - Counterparty: Perceptive Credit Holdings IV, LP
  - Rate: Term SOFR plus 7.5%
  - Maturity: October 27, 2028
  - Event: incurrence
  source text: GeneDx Holdings Corp. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) with Perceptive Credit Holdings IV, LP, as lender and administrative agent (“Perceptive”), which provides for a senior secured delayed draw term loan facility in an aggregate principal amount of up to $75.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000066/0001818331-23-000066-index.htm
- Earnings Releases
  GeneDx Holdings Corp. reported the third quarter of 2023 results: revenue $53.3 million, net income $42.3 million. Guidance lowered.
  - Period: the third quarter of 2023
  - Revenue: $53.3 million
  - Net income: $42.3 million
  - Guidance: lowered
  - Result: reported results
  source text: for the third quarter of 2023 narrowed to $21.2 million 2 , an improvement of 70% year-over-year and 45% sequentially. • Revenue 1 : Revenue for the third quarter of 2023 was $53.3 million, compared to $83.2 million in the third quarter of 2022. • Gross Margin 1 : Gross margin for the third quarter of 2023 was 47%. Adjusted gross margin for the third quarter of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000066/0001818331-23-000066-index.htm
- Material Agreements
  GeneDx Holdings Corp. entered into Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP valued at up to $75.0 million (effective 2023-10-27).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Perceptive Credit Holdings IV, LP
  - Value: up to $75.0 million
  - Effective: 2023-10-27
  source text: On October 27, 2023 (the "Closing Date"), GeneDx Holdings Corp. (the "Company") entered into a Credit Agreement and Guaranty (the "Credit Agreement") with Perceptive Credit Holdings IV, LP, as lender and administrative agent ("Perceptive"), which provides for a senior secured delayed draw term loan facility in an aggregate principal amount of up to $75.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000066/0001818331-23-000066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.